Chronic graft-versus-host disease - PubMed (original) (raw)
Review
Chronic graft-versus-host disease
Stephanie J Lee et al. Biol Blood Marrow Transplant. 2003 Apr.
Free article
Abstract
Chronic graft-versus-host disease (GVHD) remains a vexing and dangerous complication of allogeneic stem cell transplantation. Mild forms of chronic GVHD are often manageable with local or low-dose systemic immunosuppression and do not affect long-term survival. In contrast, more severe forms of chronic GVHD require intensive medical management and adversely affect survival. This report reviews current concepts of the pathogenesis, clinical risk factors, classification systems, organ manifestations, and available treatments for chronic GVHD. It also provides a comprehensive listing of the published clinical trials aimed at prevention and primary treatment of chronic GVHD.
Copyright 2003 American Society for Blood and Marrow Transplantation
Comment in
- Re: chronic graft-versus-host disease.
Flowers ME, Lee S, Vogelsang G. Flowers ME, et al. Biol Blood Marrow Transplant. 2003 Aug;9(8):540. doi: 10.1016/s1083-8791(03)00231-3. Biol Blood Marrow Transplant. 2003. PMID: 12931123 No abstract available.
Similar articles
- Ocular graft-versus-host disease: a review.
Shikari H, Antin JH, Dana R. Shikari H, et al. Surv Ophthalmol. 2013 May-Jun;58(3):233-51. doi: 10.1016/j.survophthal.2012.08.004. Epub 2013 Mar 27. Surv Ophthalmol. 2013. PMID: 23541042 Review. - Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation.
Funke VA, Moreira MC, Vigorito AC. Funke VA, et al. Rev Assoc Med Bras (1992). 2016 Oct;62 Suppl 1:44-50. doi: 10.1590/1806-9282.62.suppl1.44. Rev Assoc Med Bras (1992). 2016. PMID: 27982319 Review. - Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant.
Barton-Burke M, Dwinell DM, Kafkas L, Lavalley C, Sands H, Proctor C, Johnson E. Barton-Burke M, et al. Oncology (Williston Park). 2008 Oct;22(11 Suppl Nurse Ed):31-45. Oncology (Williston Park). 2008. PMID: 19856578 Review. - Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.
Rapoport Y, Freeman T, Koyama T, Engelhardt BG, Jagasia M, Savani BN, Tran U, Kassim AA. Rapoport Y, et al. Cornea. 2017 Feb;36(2):258-263. doi: 10.1097/ICO.0000000000001109. Cornea. 2017. PMID: 28060078 - Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.
Wolff D, Gerbitz A, Ayuk F, Kiani A, Hildebrandt GC, Vogelsang GB, Elad S, Lawitschka A, Socie G, Pavletic SZ, Holler E, Greinix H. Wolff D, et al. Biol Blood Marrow Transplant. 2010 Dec;16(12):1611-28. doi: 10.1016/j.bbmt.2010.06.015. Epub 2010 Jun 25. Biol Blood Marrow Transplant. 2010. PMID: 20601036
Cited by
- Association between early anti-cytomegalovirus therapy and the incidence of chronic graft-versus-host disease.
Miyao K, Murata M, Nishida T, Ozawa Y, Uchida N, Fukuda T, Doki N, Eto T, Kawakita T, Mori Y, Takada S, Ohigashi H, Tanaka M, Kanda Y, Matsuoka KI, Ishimaru F, Atsuta Y, Kanda J, Terakura S; GVHD Working Group of the Japanese Society for Transplantation and Cellular Therapy. Miyao K, et al. Int J Hematol. 2024 Nov 14. doi: 10.1007/s12185-024-03871-4. Online ahead of print. Int J Hematol. 2024. PMID: 39543007 - Umbilical Cord Blood Platelet Lysate Eyedrops for the Treatment of Severe Ocular Surface Disorders in Graft vs. Host Disease Patients: Clinical Study.
Gagliano C, Foti R, Zeppieri M, Maniaci A, Lavalle S, Tancredi G, Gagliano G, Avitabile A, Cannizzaro L, Foti R. Gagliano C, et al. Life (Basel). 2024 Oct 5;14(10):1268. doi: 10.3390/life14101268. Life (Basel). 2024. PMID: 39459568 Free PMC article. - Long-term outcome of 2-year survivors after allogeneic hematopoietic cell transplantation for acute leukemia.
Larue M, Labopin M, Schroeder T, Huang XJ, Blau IW, Schetelig J, Ganser A, Hamladji RM, Bethge W, Kröger N, Socié G, Salmenniemi U, Sengeloev H, Dholaria B, Savani BN, Nagler A, Ciceri F, Mohty M. Larue M, et al. Hemasphere. 2024 Oct 22;8(10):e70026. doi: 10.1002/hem3.70026. eCollection 2024 Oct. Hemasphere. 2024. PMID: 39440198 Free PMC article. - Oral Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies.
Nguyen JT, Jessri M, Costa-da-Silva AC, Sharma R, Mays JW, Treister NS. Nguyen JT, et al. Int J Mol Sci. 2024 Sep 27;25(19):10411. doi: 10.3390/ijms251910411. Int J Mol Sci. 2024. PMID: 39408739 Free PMC article. Review. - Into the storm: the imbalance in the yin-yang immune response as the commonality of cytokine storm syndromes.
Armstrong A, Tang Y, Mukherjee N, Zhang N, Huang G. Armstrong A, et al. Front Immunol. 2024 Sep 10;15:1448201. doi: 10.3389/fimmu.2024.1448201. eCollection 2024. Front Immunol. 2024. PMID: 39318634 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources